- Home
- TBLAW vs SNN Comparison
TBLAW vs SNN Comparison
Compare TBLAW & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBLAW
- SNN
- Stock Information
- Founded
- TBLAW N/A
- SNN 1856
- Country
- TBLAW Israel
- SNN United Kingdom
- Employees
- TBLAW 1900
- SNN N/A
- Industry
- TBLAW Computer Software: Programming Data Processing
- SNN Industrial Specialties
- Sector
- TBLAW Technology
- SNN Health Care
- Exchange
- TBLAW Nasdaq
- SNN Nasdaq
- Market Cap
- TBLAW N/A
- SNN 12.4B
- IPO Year
- TBLAW N/A
- SNN 1999
- Fundamental
- Price
- TBLAW $0.15
- SNN $29.44
- Analyst Decision
- TBLAW
- SNN Strong Buy
- Analyst Count
- TBLAW 0
- SNN 1
- Target Price
- TBLAW N/A
- SNN N/A
- AVG Volume (30 Days)
- TBLAW N/A
- SNN 674.7K
- Earning Date
- TBLAW N/A
- SNN 08-01-2024
- Dividend Yield
- TBLAW N/A
- SNN 2.55%
- EPS Growth
- TBLAW N/A
- SNN 39.77
- EPS
- TBLAW N/A
- SNN 0.35
- Revenue
- TBLAW N/A
- SNN $5,642,000,000.00
- Revenue This Year
- TBLAW N/A
- SNN $6.92
- Revenue Next Year
- TBLAW N/A
- SNN $5.43
- P/E Ratio
- TBLAW N/A
- SNN $41.81
- Revenue Growth
- TBLAW N/A
- SNN 5.48
- 52 Week Low
- TBLAW N/A
- SNN $21.53
- 52 Week High
- TBLAW N/A
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- TBLAW N/A
- SNN 46.87
- Support Level
- TBLAW N/A
- SNN $28.26
- Resistance Level
- TBLAW N/A
- SNN $29.64
- Average True Range (ATR)
- TBLAW 0.00
- SNN 0.36
- MACD
- TBLAW 0.00
- SNN 0.05
- Stochastic Oscillator
- TBLAW 0.00
- SNN 58.65
About TBLAW Taboola.com Ltd. Warrant
Taboola.com Ltd is a technology company that powers recommendations across the Open Web with an artificial intelligence-based, algorithmic engine. It partners with websites, devices, and mobile apps, collectively referred to as digital properties, to recommend editorial content and advertisements on the Open Web. Geographically it serves Israel, the United Kingdom, Germany, France, Rest of the world whilst it generates the majority of its revenue from the United States.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.